Molecular and Cellular Biology, August 2000, p. 5712-5721, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
INSERM U145, IFR 50, Faculté de Médecine, 06107 Nice Cedex 2, France,1 and Friedrich Miescher Institute, CH 4002 Basel, Switzerland2
Received 2 August 1999/Returned for modification 23 September 1999/Accepted 17 April 2000
In this report we investigated the function of
phosphoinositide-dependent protein kinase 1 (PDK1) in protein kinase B
(PKB) activation and translocation to the cell surface. Wild-type and PDK1 mutants were transfected into HeLa cells, and their subcellular localization was analyzed. PDK1 was found to translocate to the plasma
membrane in response to insulin, and this process did not require a
functional catalytic activity, since a catalytically inactive kinase
mutant (Kd) of PDK1 was capable of translocating. The PDK1 presence at
the cell surface was shown to be linked to phospholipids and therefore
to serum-dependent phosphatidylinositol 3-kinase activity. Using
confocal microscopy in HeLa cells we found that PDK1 colocalizes with
PKB at the plasma membrane. Further, after cotransfection of PKB and a
PDK1 mutant (Mut) unable to translocate to the plasma membrane, PKB was
prevented from moving to the cell periphery after insulin stimulation.
In response to insulin, a PKB mutant with its PH domain deleted
(
PH-PKB) retained the ability to translocate to the plasma membrane
when coexpressed with PDK1. Finally, we found that
PH-PKB was highly
active independent of insulin stimulation when cotransfected with PDK1
mutants defective in their PH domain. These findings suggest that PDK1
brings PKB to the plasma membrane upon exposure of cells to insulin and
that the PH domain of PDK1 acts as a negative regulator of its enzyme activity.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|